Sequent Scientific
Ticker > Company >

Sequent Scientific share price

Sequent Scientific Ltd.

NSE: SEQUENT BSE: 512529 SECTOR: Pharmaceuticals & Drugs  99k   419   88

198.00
-4.90 (-2.41%)
BSE: 13 Nov 04:01 PM

Price Summary

Today's High

₹ 203.7

Today's Low

₹ 192.8

52 Week High

₹ 240.9

52 Week Low

₹ 91.85

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 4945.29 Cr.

Enterprise Value

₹ 4990.79 Cr.

No. of Shares

24.98 Cr.

P/E

414.66

P/B

4.86

Face Value

₹ 2

Div. Yield

0 %

Book Value (TTM)

₹  40.71

CASH

₹ 0.96 Cr.

DEBT

₹ 46.46 Cr.

Promoter Holding

52.76 %

EPS (TTM)

₹  0.48

Sales Growth

-24.32%

ROE

0.06 %

ROCE

0.37%

Profit Growth

110.23 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year-24.32%
3 Year-14.06%
5 Year0.27%

Profit Growth

1 Year110.23%
3 Year-73.14%
5 Year-39.36%

ROE%

1 Year0.06%
3 Year0.31%
5 Year1.34%

ROCE %

1 Year0.37%
3 Year0.45%
5 Year1.75%

Debt/Equity

0.046

Price to Cash Flow

-183.54

Interest Cover Ratio

0.9452

CFO/PAT (5 Yr. Avg.)

0.839366191575762

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2024 52.76 0.00
Jun 2024 52.78 0.00
Mar 2024 52.79 0.00
Dec 2023 52.79 0.00
Sep 2023 52.79 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company is virtually debt free.
  • The company has an efficient Cash Conversion Cycle of 22.0103 days.
  • The company has a high promoter holding of 52.76%.

 Limitations

  • The company has shown a poor profit growth of -73.1442984570143% for the Past 3 years.
  • The company has shown a poor revenue growth of -14.0555118942519% for the Past 3 years.
  • Company has a poor ROE of 0.306982105668217% over the past 3 years.
  • Company has a poor ROCE of 0.449786878756407% over the past 3 years
  • Company has negative cash flow from operations of -26.944.
  • The company has a low EBITDA margin of -2.9547784594462% over the past 5 years.
  • The company is trading at a high PE of 414.66.
  • The company is trading at a high EV/EBITDA of 181.167.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024
Net Sales 40.42 49.12 42.21 36.77 57.67
Total Expenditure 49.49 56.82 46.36 42.51 59.65
Operating Profit -9.07 -7.7 -4.16 -5.74 -1.98
Other Income 9.7 9.87 13.44 12.98 10.84
Interest 0.98 1.21 1.15 1.03 0.81
Depreciation 2.43 2.35 2.05 2.11 2
Exceptional Items -6.25 0 0 0 0
Profit Before Tax -9.03 -1.4 6.09 4.1 6.05
Tax -2.23 -0.48 1.51 0.34 1.55
Profit After Tax -6.8 -0.92 4.58 3.76 4.5
Adjusted EPS (Rs) -0.27 -0.04 0.18 0.15 0.18

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 227.33 265.46 219.63 222.69 168.52
Total Expenditure 206.84 241.5 231.59 249.09 195.18
Operating Profit 20.49 23.96 -11.97 -26.4 -26.66
Other Income 16.31 31.3 38.86 28.29 45.98
Interest 5.04 2.68 1.61 2.51 4.36
Depreciation 8.95 9.13 9.59 9.12 8.94
Exceptional Items 0 -2.56 0 0 -6.25
Profit Before Tax 22.81 40.89 15.69 -9.75 -0.24
Tax 1.47 8.77 0.89 -3.67 -0.86
Net Profit 21.34 32.11 14.8 -6.08 0.62
Adjusted EPS (Rs.) 0.86 1.29 0.6 -0.24 0.02

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 49.67 49.67 49.67 49.89 49.89
Total Reserves 836.54 979.84 991.41 1008.48 1037.34
Borrowings 15.17 0 0 0 0
Other N/C liabilities -3.67 4.81 19.26 -9.43 -9.38
Current liabilities 105.24 96.62 89.56 61.61 98.16
Total Liabilities 1002.96 1130.94 1149.9 1110.54 1176
Assets
Net Block 69.41 65.78 66.9 56.72 42.52
Capital WIP 3.72 4.34 1.4 2.2 5.14
Intangible WIP 0 0 0 0 0
Investments 738.95 685.11 658.47 632.47 640.3
Loans & Advances 66.37 230.43 267.66 333.48 382.3
Other N/C Assets 0.55 0.29 0.6 10.65 8.97
Current Assets 123.95 144.99 154.86 75.02 96.78
Total Assets 1002.96 1130.94 1149.9 1110.54 1176
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 22.81 43.45 15.69 -9.75 -0.24
Adjustment 1.74 1.12 -6.38 -0.49 -18.19
Changes in Assets & Liabilities 7.84 -25.47 1.81 48.68 -10.77
Tax Paid -2.19 -16.76 -1.75 -0.7 2.26
Operating Cash Flow 30.2 2.34 9.36 37.75 -26.94
Investing Cash Flow -17.69 16.55 -4.25 -50.7 5.47
Financing Cash Flow -10.71 -21.33 7.25 0.24 22.32
Net Cash Flow 1.81 -2.44 12.36 -12.71 0.84

Corporate Actions

Investors Details

PARTICULARS Sep 2023% Dec 2023% Mar 2024% Jun 2024% Sep 2024%
promoters 52.79 52.79 52.79 52.78 52.76
ca harbor investments 52.79 52.79 52.79 52.78 52.76
PARTICULARS Sep 2023% Dec 2023% Mar 2024% Jun 2024% Sep 2024%
investors 47.21 47.21 47.21 47.22 47.24
ashoka whiteoak icav - as... - 1.64 1.64 1.63 1.63
investor education and pr... 0.01 - 0.01 - 0.01
quant mutual fund - quant... - - 4.79 - 6.93
investor education and pr... - 0.01 - 0.01 -
quant mutual fund - quant... - 4.67 - 5.26 -
unit trust of india inves... - - 3.33 3.33 -
public sector pension inv... - 1.14 1.14 - -
turnaround opportunities ... - 1.15 - - -
unit trust of india inves... - 3.33 - - -

Annual Reports

Ratings & Research Reports

Company Presentations

Company News

Sequent Scientific informs about investor presentation 27 Sep, 9:55 AM Sequent Scientific receives WHO prequalification approval for Albendazole API 19 Aug, 5:58 PM Sequent Scientific - Quaterly Results 14 Aug, 7:49 PM Sequent Scientific informs about compliances-certificate 18 Jul, 5:00 PM Sequent Scientific informs about compliance report 30 May, 3:08 PM Sequent Scientific - Quaterly Results 15 May, 8:09 PM Sequent Scientific - Quaterly Results 15 May, 8:09 PM Sequent Scientific informs about analysts meet 13 May, 10:49 AM Sequent Scientific informs about resignation of Managing Director 4 Apr, 12:45 PM Sequent Scientific - Quaterly Results 13 Feb, 8:53 PM Sequent Scientific - Quaterly Results 13 Feb, 8:53 PM Sequent Scientific to sell plot located in Ambernath Industrial Area 8 Feb, 6:19 PM Sequent Scientific informs about transcript of earnings call 13 Nov, 5:17 PM Sequent Scientific - Quaterly Results 6 Nov, 10:02 PM Sequent Scientific - Quaterly Results 6 Nov, 10:02 PM USFDA completes inspection at Sequent Scientific’s Visakhapatnam manufacturing facility 25 Sep, 10:37 AM Sequent Scientific gets nod to sell API facility in Tarapur 15 Sep, 11:43 AM Sequent Scientific informs about rectification of inadvertent typographical error 17 Aug, 12:34 PM Sequent Scientific informs about audio recording of earnings call 11 Aug, 4:21 PM Sequent Scientific - Quaterly Results 10 Aug, 10:13 PM Sequent Scientific - Quaterly Results 10 Aug, 10:13 PM Sequent Scientific informs about appointment of director 8 Aug, 2:16 PM Sequent Scientific - Quaterly Results 23 May, 8:16 PM Sequent Scientific - Quaterly Results 23 May, 8:16 PM Sequent Scientific informs about conference call 17 May, 11:02 AM Sequent Scientific informs about non-applicability of large corporate entity 11 May, 5:23 PM Sequent Scientific informs about certificate 14 Apr, 3:46 PM Sequent Scientific informs about trading window closure 30 Mar, 1:06 PM Sequent Scientific terminates share purchase agreement with Tineta 9 Mar, 11:30 AM Sequent Scientific informs about earnings call transcript 21 Feb, 4:40 PM Sequent Scientific - Quaterly Results 14 Feb, 5:56 PM Sequent Scientific - Quaterly Results 14 Feb, 5:56 PM Sequent Scientific informs about transcript of earnings call 14 Nov, 5:19 PM Sequent Scientific gets nod to acquire 100% stake in Tineta Pharma 8 Nov, 12:58 PM Sequent Scientific - Quaterly Results 7 Nov, 8:36 PM Sequent Scientific - Quaterly Results 7 Nov, 8:36 PM Sequent Scientific informs about earnings call transcript 16 Aug, 5:06 PM Sequent Scientific - Quaterly Results 8 Aug, 9:36 PM Sequent Scientific - Quaterly Results 8 Aug, 9:36 PM Sequent Scientific - Quaterly Results 25 May, 9:08 PM Sequent Scientific - Quaterly Results 25 May, 9:08 PM Sequent Scientific informs about allotment of equity shares under ESOP 26 Apr, 4:59 PM Sequent Scientific informs about postal ballot notice 11 Apr, 12:24 PM Sequent Scientific acquires entire stake in Nourrie 2 Mar, 11:19 AM Sequent Scientific informs about acquisition 2 Mar, 10:34 AM Sequent Scientific - Quaterly Results 11 Feb, 8:06 PM Sequent Scientific - Quaterly Results 11 Feb, 8:06 PM Sequent Scientific informs about press release 15 Jan, 12:16 PM Sequent Scientific informs about change in directorate 15 Jan, 11:51 AM Sequent Scientific consolidates residual stake in Evance Group 12 Jan, 2:23 PM

Sequent Scientific Stock Price Analysis and Quick Research Report. Is Sequent Scientific an attractive stock to invest in?

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Sequent Scientific and its performance over the period of time. Sequent Scientific stock price today is Rs 195.92.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Sequent Scientific cash from the operating activity was Rs -26.944 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Sequent Scientific has a Debt to Equity ratio of 0.046 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Sequent Scientific , the EPS growth was 110.2133 % which is good for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Sequent Scientific has OPM of -15.822642091646 % which is a bad sign for profitability.
     
  • ROE: Sequent Scientific have a poor ROE of 0.0618 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Sequent Scientific is Rs 195.92. One can use valuation calculators of ticker to know if Sequent Scientific share price is undervalued or overvalued.
Last Updated on:
Brief about Sequent Scientific

Sequent Scientific Ltd. Financials: Check Share Price, Balance Sheet, Annual Report, Quarterly Results, Shareholding, Company Profile and News for Company Analysis

Sequent Scientific Limited is a leading animal health company based in India. The company focuses on developing, manufacturing, and marketing a wide range of veterinary products that promote animal health and increase productivity. Sequent Scientific Ltd. operates through two business segments, namely Animal Health and Specialty Chemicals.

The Animal Health segment of Sequent Scientific Ltd. offers a comprehensive range of innovative medicines, vaccines, and nutrition products for livestock and companion animals. The company has a global footprint, with a presence in over 100 countries, and is committed to ensuring animal health and welfare across the world.

The Specialty Chemicals segment of Sequent Scientific Ltd. serves a wide range of industries, including agrochemicals, pharmaceuticals, and personal care. The segment produces a variety of specialty chemicals, such as surfactants, emulsifiers, and performance additives, that are used as raw materials in various industries.

Sequent Scientific Ltd. Share Price

The Sequent Scientific Ltd. share price is a reflection of the company's performance and its future prospects. The share price is influenced by a variety of factors, including the financial performance of the company, industry trends, and market conditions.

Investors can track the Sequent Scientific Ltd. share price on our website and access price charts that provide a historical perspective on the stock's performance. Our pre-built screening tools allow investors to analyze the stock's performance based on various parameters, such as market capitalization, price-to-earnings ratio, dividend yield, and more.

Sequent Scientific Ltd. Balance Sheet

The balance sheet is an important financial document that provides a snapshot of a company's financial position at a specific point in time. The Sequent Scientific Ltd. balance sheet reflects the company's assets, liabilities, and shareholder equity.

Investors can access the Sequent Scientific Ltd. balance sheet on our website, along with other financial statements such as the profit and loss statement and cash flow statement. Our premium features allow investors to perform fair value calculations using tools such as DCF analysis, BVPS analysis, earnings multiple approach, and DuPont analysis.

Sequent Scientific Ltd. Annual Report

The Sequent Scientific Ltd. annual report provides a comprehensive overview of the company's financial performance, business operations, and future prospects. The annual report is a valuable resource for investors who want to gain insight into the company's strategy and growth prospects.

Investors can download the Sequent Scientific Ltd. annual report from our website to stay up-to-date with the company's performance and future plans.

Sequent Scientific Ltd. Dividend

The Sequent Scientific Ltd. dividend is a reflection of the company's financial performance and its commitment to shareholders. The company has a track record of consistently paying dividends to its shareholders.

Investors can access information on the Sequent Scientific Ltd. dividend on our website and track the dividend yield and payout ratio. Our screening tools allow investors to screen stocks based on dividend yield, payout ratio, and other parameters.

Sequent Scientific Ltd. Quarterly Result

The Sequent Scientific Ltd. quarterly result is an important indicator of the company's financial performance and its ability to meet its short-term goals. The quarterly result includes information on the company's revenue, profit, and other key financial metrics.

Investors can access the Sequent Scientific Ltd. quarterly result on our website and analyze the company's performance using our premium features. Our fair value calculation tools allow investors to estimate the intrinsic value of the stock based on various financial parameters.

Sequent Scientific Ltd. Stock Price

The Sequent Scientific Ltd. stock price is influenced by market conditions, industry trends, and the company's financial performance. Investors can access the latest information on the stock price on our website and track historical trends using our price charts.

Our pre-built screening tools allow investors to screen stocks based on various parameters, such as market capitalization, price-to-earnings ratio, and dividend yield. Investors can use these tools to identify stocks that meet their investment criteria.

Sequent Scientific Ltd. Price Chart

The Sequent Scientific Ltd. price chart is a valuable resource for investors who want to track the stock's performance over time. The price chart provides a historical perspective on the stock's price movements and helps investors identify trends and patterns.

Investors can access the Sequent Scientific Ltd. price chart on our website and customize it based on their preferences. Our premium features allow investors to perform technical analysis using tools such as moving averages, Bollinger bands, and relative strength index.

Sequent Scientific Ltd. News

Investors can stay up-to-date with the latest news on Sequent Scientific Ltd. on our website. Our news section provides information on the company's business operations, financial performance, and other key developments.

Investors can use this information to make informed investment decisions and stay ahead of market trends.

Sequent Scientific Ltd. Concall Transcripts

Sequent Scientific Ltd. provides concall transcripts for investors who want to gain insights into the company's management and strategy. The concall transcripts provide information on the company's financial performance, business operations, and future prospects.

Investors can access the Sequent Scientific Ltd. concall transcripts on our website and gain valuable insights into the company's strategy and growth prospects.

Sequent Scientific Ltd. Investor Presentations

Investor presentations are a valuable resource for investors who want to gain insights into a company's strategy and growth prospects. The Sequent Scientific Ltd. investor presentations provide information on the company's financial performance, business operations, and future plans.

Investors can download the Sequent Scientific Ltd. investor presentations from our website and stay up-to-date with the company's strategy and growth prospects.

Sequent Scientific Ltd. Promoters

Sequent Scientific Ltd. has a strong group of promoters who are committed to the company's growth and success. The promoters bring their expertise and experience to the table and provide strategic guidance to the company.

Investors can access information on the Sequent Scientific Ltd. promoters on our website and gain insight into their background and experience.

Sequent Scientific Ltd. Shareholders

Sequent Scientific Ltd. has a diverse group of shareholders who are committed to the company's growth and success. The shareholders include institutional investors, retail investors, and other stakeholders.

Investors can access information on the Sequent Scientific Ltd. shareholders on our website and gain insight into their investment patterns and strategies.

Read More
X